Diffuse Large B-cell Lymphomas With Plasmablastic Differentiation Represent a Heterogeneous Group of Disease Entities

Plasmablastic lymphoma was initially described as a variant of diffuse large B-cell lymphoma (DLBCL) involving the oral cavity of HIV+ patients and characterized by immunoblastic morphology and a plasma cell phenotype. However, other lymphomas may exhibit similar morphologic and immunophenotypic features. To determine the significance of plasmablastic differentiation in DLBCL and examine the heterogeneity of lymphomas with these characteristics, we examined 50 DLBCLs with low/absent CD20/CD79a and an immunophenotype indicative of terminal B-cell differentiation (MUM1/CD38/CD138/EMA-positive). We were able to define several distinct subgroups. Twenty-three tumors were classified as plasmablastic lymphoma of the oral mucosa type and showed a monomorphic population of immunoblasts with no or minimal plasmacytic differentiation. Most patients were HIV+ and EBV was positive in 74%. Eleven (48%) cases presented in the oral mucosa, but the remaining presented in other extranodal (39%) or nodal (13%) sites. Sixteen cases were classified as plasmablastic lymphoma with plasmacytic differentiation. These were composed predominantly of immunoblasts and plasmablasts, but in addition exhibited more differentiation to mature plasma cells. Only 33% were HIV+, EBV was detected in 62%, and 44% had nodal presentation. Nine cases, morphologically indistinguishable from the previous group, were secondary extramedullary plasmablastic tumors occurring in patients with prior or synchronous plasma cell neoplasms, classified as multiple myeloma in 7 of the 9. Two additional neoplasms were an HHV-8+ extracavitary variant of primary effusion lymphoma and an ALK+ DLBCL. HHV-8 was examined in 39 additional cases, and was negative in all. In conclusion, DLBCLs with plasmablastic differentiation are a heterogeneous group of neoplasms with different clinicopathological characteristics that may correspond to different entities.

[1]  G. Nuovo,et al.  Oral Plasmablastic Lymphomas in AIDS Patients Are Associated With Human Herpesvirus 8 , 2004, The American journal of surgical pathology.

[2]  J. Downing,et al.  ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript: report of 2 cases. , 2003, Blood.

[3]  P. Marynen,et al.  ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma. , 2003, Blood.

[4]  Cristina Martínez,et al.  Epstein-Barr virus-related plasmablastic lymphomas arising from long-standing sacrococcygeal cysts in immunosuppressed patients. , 2003, AIDS.

[5]  R. Dalla‐Favera,et al.  Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts. , 2003, Blood.

[6]  K. Ohshima,et al.  Senile EBV+ B-Cell Lymphoproliferative Disorders: A Clinicopathologic Study of 22 Patients , 2003, The American journal of surgical pathology.

[7]  E. Campo,et al.  Molecular histogenesis of plasmablastic lymphoma of the oral cavity , 2002, British journal of haematology.

[8]  Y. Tomita,et al.  DNA Sequences of the Immunoglobulin Heavy Chain Variable Region Gene in Pyothorax-Associated Lymphoma , 2002, Oncology.

[9]  C. Boshoff,et al.  High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. , 2002, Blood.

[10]  S. Ely,et al.  Expression of CD56/neural cell adhesion molecule correlates with the presence of lytic bone lesions in multiple myeloma and distinguishes myeloma from monoclonal gammopathy of undetermined significance and lymphomas with plasmacytoid differentiation. , 2002, The American journal of pathology.

[11]  D. Hossfeld.  E.S. Jaffe, N.L. Harris, H. Stein, J.W. Vardiman (eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues , 2002 .

[12]  T. Rasmussen,et al.  Differential expression of CD56 and CD44 in the evolution 
of extramedullary myeloma , 2002, British journal of haematology.

[13]  R. Kordek,et al.  Plasmablastic lymphoma in a patient with chronic lymphocytic leukemia heavily pretreated with cladribine (2‐CdA): an unusual variant of Richter's syndrome , 2001, European journal of haematology.

[14]  H Ye,et al.  Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. , 2001, Blood.

[15]  B. Barlogie,et al.  Cyclin D1 and E2F‐1 immunoreactivity in bone marrow biopsy specimens of multiple myeloma: relationship to proliferative activity, cytogenetic abnormalities and DNA ploidy , 2001, British journal of haematology.

[16]  C. Franceschi,et al.  Shortage of circulating naive CD8(+) T cells provides new insights on immunodeficiency in aging. , 2000, Blood.

[17]  R. Lamerz,et al.  Amplification of cyclin D1 gene in multiple myeloma: clinical and prognostic relevance , 2000, British journal of haematology.

[18]  H Stein,et al.  A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. , 2000, Blood.

[19]  C. Boshoff,et al.  HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. , 2000, Blood.

[20]  B. Grosbois,et al.  Mature plasma cells as indicator of better prognosis in multiple myeloma. New methodology for the assessment of plasma cell morphology. , 1999, Leukemia research.

[21]  E. Jaffe,et al.  A biophenotypic human herpesvirus 8--associated primary bowel lymphoma. , 1999, The American journal of surgical pathology.

[22]  M. Kremer,et al.  Extramedullary plasmacytoma , 1999 .

[23]  T. Therneau,et al.  Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  A. Órfão,et al.  Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics. , 1999, Blood.

[25]  M. Taniwaki,et al.  Amplification and overexpression of the PRAD1/Cyclin D1 gene in a multiple myeloma cell line. , 1998, International journal of hematology.

[26]  F. Lionnet,et al.  Acute myeloid leukemias, multiple myelomas, and chronic leukemias in the setting of HIV infection. , 1998, AIDS patient care and STDs.

[27]  R. Bataille,et al.  The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma , 1998, Leukemia.

[28]  E. Cesarman,et al.  Immunoglobulin VH gene mutational analysis suggests that primary effusion lymphomas derive from different stages of B cell maturation. , 1998, The American journal of pathology.

[29]  Joan,et al.  Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma. , 1998, The American journal of pathology.

[30]  G. Gaidano,et al.  AIDS-related extranodal non-Hodgkin's lymphomas with plasma cell differentiation. , 1997, Blood.

[31]  S. de Vos,et al.  Kaposi's sarcoma-associated herpesvirus and human herpesvirus 8 (KSHV/HHV8)-associated lymphoma of the bowel. Report of two cases in HIV-positive men with secondary effusion lymphomas. , 1997, The American journal of surgical pathology.

[32]  B. Nathwani,et al.  A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin's lymphoma: a report of the Non-Hodgkin's Lymphoma Classification Project , 1997 .

[33]  P. Brousset,et al.  A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation. , 1997, Blood.

[34]  D. Huhn,et al.  Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. , 1997, Blood.

[35]  K. Pulford,et al.  Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. , 1997, Blood.

[36]  E. Jaffe,et al.  Detection of HHV-8/KSHV DNA sequences in AIDS-associated extranodal lymphoid malignancies. , 1996, Leukemia.

[37]  R. Bataille,et al.  Adhesion molecules on human myeloma cells: significant changes in expression related to malignancy, tumor spreading, and immortalization. , 1995, Cancer research.

[38]  S. Swerdlow,et al.  Extramedullary plasmacytoma of the head and neck: use of paraffin sections to assess clonality with in situ hybridization, growth fraction, and the presence of Epstein-Barr virus. , 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[39]  V. Schnadig,et al.  Plasma cell myeloma in patients who are HIV-positive. , 1994, American journal of clinical pathology.

[40]  R. Bataille,et al.  Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells. , 1994, Blood.

[41]  P. Coates,et al.  Epstein Barr virus (EBV) encoded small RNAs: targets for detection by in situ hybridisation with oligonucleotide probes. , 1992, Journal of clinical pathology.

[42]  D. Shibata,et al.  Epstein-Barr virus and Hodgkin's disease. A correlative in situ hybridization and polymerase chain reaction study. , 1991, American Journal of Pathology.

[43]  S. Linn,et al.  Prognostic significance of plasma cell morphology in multiple myeloma , 1987, Cancer.

[44]  G. Ott,et al.  Diffuse large B-cell lymphomas with plasmablastic/plasmacytoid features are associated with TP53 deletions and poor clinical outcome , 2004, Leukemia.

[45]  R. Gascoyne,et al.  ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of six cases , 2003 .

[46]  Emili Montserrat,et al.  Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma. , 2003, Blood.

[47]  C. Flaitz,et al.  Plasmablastic lymphoma: an HIV-associated entity with primary oral manifestations. , 2002 .

[48]  G. Dini,et al.  Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies. , 2000, Haematologica.

[49]  P. Galieni,et al.  Clinical outcome of extramedullary plasmacytoma. , 2000, Haematologica.

[50]  Koichiro Nakamura,et al.  Human Herpesvirus 8–Associated Solid Lymphomas that Occur in AIDS Patients Take Anaplastic Large Cell Morphology , 2000, Modern Pathology.

[51]  James Olen Armitage,et al.  A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. , 1997, Blood.